These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 37751026)

  • 41. Targeting copper metabolism: a promising strategy for cancer treatment.
    Kong R; Sun G
    Front Pharmacol; 2023; 14():1203447. PubMed ID: 37564178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cuproptosis: emerging biomarkers and potential therapeutics in cancers.
    Wang M; Zheng L; Ma S; Lin R; Li J; Yang S
    Front Oncol; 2023; 13():1288504. PubMed ID: 38023234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
    Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
    Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent Advances in Copper-Based Organic Complexes and Nanoparticles for Tumor Theranostics.
    Tsymbal S; Li G; Agadzhanian N; Sun Y; Zhang J; Dukhinova M; Fedorov V; Shevtsov M
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
    Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
    Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy.
    De Luca A; Barile A; Arciello M; Rossi L
    J Trace Elem Med Biol; 2019 Sep; 55():204-213. PubMed ID: 31345360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive exploration of the involvement of cuproptosis in tumorigenesis and progression of neuroblastoma.
    Zhou R; Huang D; Fu W; Shu F
    BMC Genomics; 2023 Nov; 24(1):715. PubMed ID: 38012558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma.
    Lei G; Tang L; Yu Y; Bian W; Yu L; Zhou J; Li Y; Wang Y; Du J
    Biomed Pharmacother; 2023 Nov; 167():115522. PubMed ID: 37757497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Copper in tumors and the use of copper-based compounds in cancer treatment.
    da Silva DA; De Luca A; Squitti R; Rongioletti M; Rossi L; Machado CML; Cerchiaro G
    J Inorg Biochem; 2022 Jan; 226():111634. PubMed ID: 34740035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The huge potential of targeting copper status in the treatment of colorectal cancer.
    Jiang Z; Sha G; Zhang W; Zhang Z; Liu T; Wang D; Tang D
    Clin Transl Oncol; 2023 Jul; 25(7):1977-1990. PubMed ID: 36781599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New developments in the regulation of intestinal copper absorption.
    van den Berghe PV; Klomp LW
    Nutr Rev; 2009 Nov; 67(11):658-72. PubMed ID: 19906252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper metabolism in cell death and autophagy.
    Xue Q; Kang R; Klionsky DJ; Tang D; Liu J; Chen X
    Autophagy; 2023 Aug; 19(8):2175-2195. PubMed ID: 37055935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.
    Chen X; Cai Q; Liang R; Zhang D; Liu X; Zhang M; Xiong Y; Xu M; Liu Q; Li P; Yu P; Shi A
    Cell Death Dis; 2023 Feb; 14(2):105. PubMed ID: 36774340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomics revealed the crosstalk between copper stress and cuproptosis, and explored the feasibility of curcumin as anticancer copper ionophore.
    Yang Y; Liang S; Geng H; Xiong M; Li M; Su Q; Jia F; Zhao Y; Wang K; Jiang J; Qin S; Li X
    Free Radic Biol Med; 2022 Nov; 193(Pt 2):638-647. PubMed ID: 36395954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Regulations diversity of fungal copper homeostasis--a review].
    Zhu C; Pan J; Yan B; Zhu X
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):841-7. PubMed ID: 19873745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment.
    Gupte A; Mumper RJ
    Cancer Treat Rev; 2009 Feb; 35(1):32-46. PubMed ID: 18774652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Copper chalcogenide materials as photothermal agents for cancer treatment.
    Liu K; Liu K; Liu J; Ren Q; Zhao Z; Wu X; Li D; Yuan F; Ye K; Li B
    Nanoscale; 2020 Feb; 12(5):2902-2913. PubMed ID: 31967164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifaceted Roles of Copper Ions in Anticancer Nanomedicine.
    Yang S; Song Y; Hu Y; Chen H; Yang D; Song X
    Adv Healthc Mater; 2023 Sep; 12(23):e2300410. PubMed ID: 37027332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copper-based nanomaterials for cancer theranostics.
    Zhong X; Dai X; Wang Y; Wang H; Qian H; Wang X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1797. PubMed ID: 35419993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.